SEC Form 4 · accession 0001127602-15-015214
ARIAD PHARMACEUTICALS INC · ARIA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Timothy P Clackson
Officer — President, R&D, CSO
Period of report
Apr 23, 2015
Accepted (ET)
Apr 27, 2015 · 4:14 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000884731
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Apr 23, 2015 | S | 123,766 | $9.50 | D | 316,548 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1This sale was effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person in June 2014.